About US

Chikujee is focused on developing therapeutic target specific multifunctional nanobindi to capitalize on the enormous opportunity to improve on currently marketed blockbuster drugs or enable the delivery of novel classes of therapeutics. Our proprietary product engine is focused on improving the efficacy and expanding the applicability of existing blockbuster drugs. We anticipate our first product entering the clinic in 2009.

The need to accelerate the transition of nanotechnology into practical use is gaining increasing importance. A variety of new nanocomposites material formulations do already exist but they often do not correspond to the functional need of biological sciences. There is still a lack in providing biopharmaceutical companies with nanoparticles and small series of new designed multifunctional nanocomposites for biological applications. Engineered nanoparticles are used in nanocomposites and coatings for biomedical applications such as antibacterial implants or catheters, targeted drug delivery, and drug formulations. Very often the desired range of applications is restricted due to a limited availability of nanoparticle materials, their purity, their re-dispersability (e.g. of agglomerated powders) and costs (specially for small amounts like pre-series). We are currently developing new methodologies for development of custom matrix nanocomposites for biological applications using silica hybrids, biodegradable polymers and biocompatible materials. Our initial emphasis is on generating small amounts of custom matrix nanomaterials by biomimentics and ultra short pulsed laser ablation. This method allows a design of new functionalities of polymer composites due to nanoparticle derived effects. The use of a variety of materials and liquids underlies almost no restrictions. As shown at the example of a bioactive product, the novel manufacturing route gives access to rapid nanomaterial generation and variation of properties, e.g. for pre-clinical studies.